YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis

YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis

Recent studies have reported that oncoprotein YAP can function as tumour suppressor in certain contexts. Here the authors show that inhibition of Hippo signalling or YAP activation blocks ERα transcriptional program and ER + breast cancer growth and mechanistically this is through YAP interfering wi...

Full description

Bibliographic Details
Main Authors: Xu Li, Shu Zhuo, Ting Zhuang, Yong Suk Cho, Guojin Wu, Yuchen Liu, Kun Mu, Kai Zhang, Peng Su, Yingzi Yang, Cheng Cheng Zhang, Jian Zhu, Jin Jiang
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-30831-5

Internet

https://doi.org/10.1038/s41467-022-30831-5

Similar Items